22q11 Deletion syndrome: A role for TBX1 in pharyngeal and cardiovascular development

Pediatric Cardiology

Volumn 31, Issue 3, 2010, Pages 378-390

  Scambler, Peter J ^a  

^a NONE

Author keywords

Great vessel development; Tbx1 epistasis; Tbx1 haploinsufficiency

Indexed keywords

BONE MORPHOGENETIC PROTEIN RECEPTOR 1A; CHORDIN; CRK LIKE PROTEIN; CYTOCHROME P450 26A1; FIBROBLAST GROWTH FACTOR; FIBROBLAST GROWTH FACTOR 10; FIBROBLAST GROWTH FACTOR 8; RETINOIC ACID; SERUM RESPONSE FACTOR; SMAD1 PROTEIN; SONIC HEDGEHOG PROTEIN; TRANSCRIPTION FACTOR NKX2.5; TRANSCRIPTION FACTOR PITX2; TRANSCRIPTION FACTOR PITX2C; UNCLASSIFIED DRUG; VASCULOTROPIN;

ALDH1 A2 GENE; ANGIOGENESIS; CHROMOSOME 16; CHROMOSOME 22Q; CHROMOSOME DELETION; CHROMOSOME INSERTION; CONFERENCE PAPER; CONGENITAL HEART MALFORMATION; CYP26B1 GENE; CYP26C1 GENE; DIGEORGE SYNDROME; EMBRYO DEVELOPMENT; ENDOTHELIUM; FACE DYSMORPHIA; FALLOT TETRALOGY; GBX2 GENE; GENE CONTROL; GENE DOSAGE; GENE EXPRESSION; GENE FUNCTION; GENE INTERACTION; GENE MAPPING; GENE MUTATION; GENE TARGETING; GENETIC TRANSCRIPTION; HEART DEVELOPMENT; HEART RIGHT VENTRICLE DOUBLE OUTLET; HEART VENTRICLE SEPTUM DEFECT; HUMAN; INNER EAR MALFORMATION; MUTAGENESIS; NEURAL CREST; NONHUMAN; PHARYNX; PHENOTYPE; REGULATOR GENE; TBX1 GENE; TISSUE SPECIFICITY; VELOCARDIOFACIAL SYNDROME;

ANIMALS; BRANCHIAL REGION; DIGEORGE SYNDROME; DISEASE MODELS, ANIMAL; GENE DELETION; HEART; HEART DEFECTS, CONGENITAL; MICE; MUTATION; PHENOTYPE; SIGNAL TRANSDUCTION; SYNDROME; T-BOX DOMAIN PROTEINS; TRETINOIN;

EID: 77954759086     PISSN: 01720643     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00246-009-9613-0     Document Type: Conference Paper

References (92)

1. Aggarwal VS, Morrow BE (2008) Genetic modifiers of the physical malformations in velo-cardio-facial syndrome/DiGeorge syndrome. Dev Disabil Res Rev 14:19-25.
2. Aggarwal VS, Liao J, Bondarev A, Schimmang T, Lewandoski M, Locker J, Shanske A, Campione M, Morrow BE (2006) Dissection of Tbx1 and Fgf interactions in mouse models of 22q11DS suggests functional redundancy. Hum Mol Genet 15: 3219-3228.
3. Arnold JS, Werling U, Braunstein EM, Liao J, Nowotschin S, Edelmann W, Hebert JM, Morrow BE (2006) Inactivation of Tbx1 in the pharyngeal endoderm results in 22q11DS malformations. Development 133:977-987.
4. Ataliotis P, Ivins S, Mohun TJ, Scambler PJ (2005) XTbx1 is a transcriptional activator involved in head and pharyngeal arch development in Xenopus laevis. Dev Dyn 232:979-991.
5. Bachiller D, Klingensmith J, Shneyder N, Tran U, Anderson R, Rossant J, De Robertis EM (2003) The role of chordin/Bmp signals in mammalian pharyngeal development and DiGeorge syndrome. Development 130:3567-3578.
6. Bergman A, Blennow E (2000) Inv dup(22), del(22)(q11) and r(22) in the father of a child with DiGeorge syndrome. Eur J Hum Genet 8:801-804.
7. Braunstein EM, Crenshaw Iii EB, Morrow BE, Adams JC (2008) Cooperative Function of Tbx1 and Brn4 in the Periotic Mesenchyme is Necessary for Cochlea Formation. J Assoc Res Otolaryngol 9:33-43.
8. Braunstein EM, Monks DC, Aggarwal VS, Arnold JS, Morrow BE (2009) Tbx1 and Brn4 regulate retinoic acid metabolic genes during cochlear morphogenesis. BMC Dev Biol 9:31.
9. Brown CB, Wenning JM, Lu MM, Epstein DJ, Meyers EN, Epstein JA (2004) Cremediated excision of Fgf8 in the Tbx1 expression domain reveals a critical role for Fgf8 in cardiovascular development in the mouse. Dev Biol 267:190-202.
10. Byrd NA, Meyers EN (2005) Loss of Gbx2 results in neural crest cell patterning and pharyngeal arch artery defects in the mouse embryo. Dev Biol 284:233-245.
11. Cabuk F, Karabulut HG, Tuncali T, Karademir S, Bozdayi M, Tukun A (2007) TBX1 gene mutation screening in patients with non-syndromic Fallot tetralogy. Turk J Pediatr 49:61-68.
12. Calmont A, Ivins S, Van Bueren KL, Papangeli I, Kyriakopoulou V, Andrews WD, Martin JF, Moon AM, Illingworth EA, Basson MA, Scambler PJ (2009) Tbx1 controls cardiac neural crest cell migration during arch artery development by regulating Gbx2 expression in the pharyngeal ectoderm. Development 136:3173- 3183.
13. Carelle-Calmels N, Saugier-Veber P, Girard-Lemaire F, Rudolf G, Doray B, Guerin E, Kuhn P, Arrive M, Gilch C, Schmitt E, Fehrenbach S, Schnebelen A, Frebourg T, Flori E (2009) Genetic compensation in a human genomic disorder. N Engl J Med 360:1211-1216.
14. Carey AH, Kelly D, Halford S, Wadey R, Wilson D, Goodship J, Burn J, Paul T, Sharkey A, Dumanski J, Nordenskjold M, Williamson R, Scambler PJ (1992) Molecular genetic study of the frequency of monosomy 22q11 in DiGeorge syndrome. Am J Hum Genet 51:964-970.
15. Caterino M, Ruoppolo M, Fulcoli G, Huynth T, Orru S, Baldini A, Salvatore F (2009) Transcription factor TBX1 overexpression induces downregulation of proteins involved in retinoic acid metabolism: a comparative proteomic analysis. J Proteome Res 8(3):1515-1526.
16. Chen L, Fulcoli FG, Tang S, Baldini A (2009) Tbx1 regulates proliferation and differentiation of multipotent heart progenitors. Circ Res 105:842-851.
17. Chieffo C, Garvey N, Gong W, Roe B, Zhang G, Silver L, Emanuel BS, Budarf ML (1997) Isolation and characterization of a gene from the DiGeorge chromosomal region homologous to the mouse Tbx1 gene. Genomics 43:267-277.
18. Choi M, Klingensmith J (2009) Chordin is a modifier of Tbx1 for the craniofacial malformations of 22q11 deletion syndrome phenotypes in mouse. PLoS Genet 5:e1000395.
19. Conti E, Grifone N, Sarkozy A, Tandoi C, Marino B, Digilio MC, Mingarelli R, Pizzuti A, Dallapiccola B (2003) DiGeorge subtypes of nonsyndromic conotruncal defects: evidence against a major role of TBX1 Gene. Eur J Hum Genet 11:349-351.
20. DiGeorge AM (1965) Discussion. J Pediatr 67:907.
21. Du Montcel ST, Mendizabal H, Ayme S, Levy A, Philip N (1996) Prevalence of 22q11 microdeletion. J Med Genet 33:719.
22. Edelmann L, Pandita R, Spiteri E, Funke B, Goldberg R, Palanisamy N, Chaganti RSK, Magenis RE, Shprintzen RJ, Morrow BE (1999) A common molecular basis for rearrangement disorders on chromosome 22q11. Hum Mol Genet 8:1157-1167.
23. Emanuel BS, Budarf BS, Scambler PJ (1998) The genetic basis of conotruncal heart defects: the chromosome 22q11.2 deletion. In: Rosenthal N, Harvey R (eds) Heart development. Academic Press, London, pp 463-478.
24. Feiner L, Webber AL, Brown CB, Lu MM, Jia L, Feinstein P, Mombaerts P, Epstein JA, Raper JA (2001) Targeted disruption of semaphorin 3C leads to persistent truncus arteriosus and aortic arch interruption. Development 128:3061-3070.
25. Feller SM (2001) Crk family adaptors-signalling complex formation and biological roles. Oncogene 20:6348-6371.
26. Franco D, Campione M (2003) The role of Pitx2 during cardiac development. Linking left-right signaling and congenital heart diseases. Trends Cardiovasc Med 13:157-163.
27. Frank DU, Fotheringham LK, Brewer JA, Muglia LJ, Tristani-Firouzi M, Capecchi MR, Moon AM (2002) An Fgf8 mouse mutant phenocopies human 22q11 deletion syndrome. Development 129:4591-4603.
28. Gong W, Gottlieb S, Collins J, Blescia A, Dietz H, Goldmuntz E, McDonald-McGinn DM, Zackai EH, Emanuel BS, Driscoll DA, Budarf ML (2001) Mutation analysis of TBX1 in non-deleted patients with features of DGS/VCFS or isolated cardiovascular defects. J Med Genet 38:E45.
29. Goodship J, Cross I, Scambler P, Burn J (1995) Monozygotic twins with chromosome 22q11 deletion and discordant phenotype. J Med Genet 32:746-748.
30. Guris DL, Fantes J, Tara D, Druker BJ, Imamoto A (2001) Mice lacking the homologue of the human 22q11.2 gene CRKL phenocopy neurocristopathies of DiGeorge syndrome. Nat Genet 27: 293-298.
31. Guris DL, Duester G, Papaioannou VE, Imamoto A (2006) Dosedependent interaction of Tbx1 and Crkl and locally aberrant RA signaling in a model of del22q11 syndrome. Dev Cell 10:81-92.
32. Halford S, Lindsay E, Nayudu M, Carey AH, Baldini A, Scambler PJ (1993) Low-copy-repeat sequences flank the DiGeorge/velo-cardio-facial syndrome loci at 22q11. Hum Mol Genet 2:191-196.
33. Hu T, Yamagishi H, Maeda J, McAnally J, Yamagishi C, Srivastava D (2004) Tbx1 regulates fibroblast growth factors in the anterior heart field through a reinforcing autoregulatory loop involving forkhead transcription factors. Development 131:5491-5502.
34. Huynh T, Chen L, Terrell P, Baldini A (2007) A fate map of Tbx1 expressing cells reveals heterogeneity in the second cardiac field. Genesis 45:470-475.
35. Ivins S, Lammerts van Beuren K, Roberts C, James C, Lindsay E, Baldini A, Ataliotis P, Scambler PJ (2005) Microarray analysis detects differentially expressed genes in the pharyngeal region of mice lacking Tbx1. Dev Biol 285:554-569.
36. Jerome LA, Papaioannou VE (2001) DiGeorge syndrome phenotype in mice mutant for the T-box gene, Tbx1. Nat Genet 27:286-291.
37. Jia L, Cheng L, Raper J (2005) Slit/Robo signaling is necessary to confine early neural crest cells to the ventral migratory pathway in the trunk. Dev Biol 282:411-421.
38. Jones CA, London NR, Chen H, Park KW, Sauvaget D, Stockton RA, Wythe JD, Suh W, Larrieu-Lahargue F, Mukouyama YS, Lindblom P, Seth P, Frias A, Nishiya N, Ginsberg MH, Gerhardt H, Zhang K, Li DY (2008) Robo4 stabilizes the vascular network by inhibiting pathologic angiogenesis and endothelial hyperpermeability. Nat Med 14:448-453.
39. Kelly RG, Papaioannou VE (2007) Visualization of outflow tract development in the absence of Tbx1 using an FgF10 enhancer trap transgene. Dev Dyn 236:821-828.
40. Kita A, Imayoshi I, Hojo M, Kitagawa M, Kokubu H, Ohsawa R, Ohtsuka T, Kageyama R, Hashimoto N (2007) Hes1 and Hes5 control the progenitor pool, intermediate lobe specification, and posterior lobe formation in the pituitary development. Mol Endocrinol 21:1458-1466.
41. Kobayashi T, Mizuno H, Imayoshi I, Furusawa C, Shirahige K, Kageyama R (2009) The cyclic gene Hes1 contributes to diverse differentiation responses of embryonic stem cells. Genes Dev 23: 1870-1875.
42. Lammer EJ, Chen DT, Hoar ND, Agnish PJ, Benke JT, Braun CJ, Curry PM, Fernhoff AW, Grix AT, Lott JM, Richard JM, Sun SC (1986) Retinoic acid embryopathy. A new human teratogen and a mechanistic hypothesis. N Engl J Med 313:837-841.
43. Larsson H, Klint P, Landgren E, Claesson-Welsh L (1999) Fibroblast growth factor receptor-1-mediated endothelial cell proliferation is dependent on the Src homology (SH) 2/SH3 domain-containing adaptor protein Crk. J Biol Chem 274:25726- 25734.
44. Layman WS, McEwen DP, Beyer LA, Lalani SR, Fernbach SD, Oh E, Swaroop A, Hegg CC, Raphael Y, Martens JR, Martin DM (2009) Defects in neural stem cell proliferation and olfaction in Chd7 deficient mice indicate a mechanism for hyposmia in human CHARGE syndrome. Hum Mol Genet 18:1909-1923.
45. Lewin MB, Lindsay EA, Jurecic V, Goytia V, Towbin JA, Baldini A (1997) A genetic etiology for interruption of the aortic arch type B. Am J Cardiol 80:493-497.
46. Li JY, Lao Z, Joyner AL (2002) Changing requirements for Gbx2 in development of the cerebellum and maintenance of the mid/hindbrain organizer. Neuron 36:31-43.
47. Liao J, Kochilas L, Nowotschin S, Arnold JS, Aggarwal VS, Epstein JA, Brown MC, Adams J, Morrow BE (2004) Full spectrum of malformations in velo-cardio-facial syndrome/Di- George syndrome mouse models by altering Tbx1 dosage. Hum Mol Genet 13:1577-1585.
48. Liao J, Aggarwal VS, Nowotschin S, Bondarev A, Lipner S, Morrow BE (2008) Identification of downstream genetic pathways of Tbx1 in the second heart field. Dev Biol 316:524-537.
49. Lindsay EA, Baldini A (2001) Recovery from arterial growth delay reduces penetrance of cardiovascular defects in mice deleted for the DiGeorge syndrome region. Hum Mol Genet 10: 997-1002.
50. Lindsay EA, Botta A, Jurecic V, Carattini-Rivera S, Cheah Y-C, Rosenblatt HM, Bradley A, Baldini A (1999) Congenital heart disease in mice deficient for the DiGeorge syndrome region. Nature 401:379-383.
51. Lindsay EA, Vitelli F, Su H, Morishima M, Huynh T, Pramparo T, Jurecic V, Ogunrinu G, Sutherland HF, Scambler PJ, Bradley A, Baldini A (2001) Tbx1 haploinsufficiency identified by functional scanning of the DiGeorge syndrome region is the cause of aortic arch defects in mice. Nature 401:97-101.
52. Merscher S, Funke B, Epstein JA, Heyer J, Puech A, Lu MM, Xavier RJ, Demay MB, Russell RG, Factor S, Tokooya K, St. Jore B, Lopez M, Pandita RK, Lia M, Carrion D, Schorle H, Kobler JR, Scambler PJ, Wynshaw-Boris A, Skoultchi A, Morrow BE, Kucherlapati R (2001) TBX1 is responsible for the cardiovascular defects in velo-cardio-facial/DiGeorge syndrome. Cell 104:619-629.
53. Meyers EN, Lewandoski M, Martin GR (1998) An Fgf8 mutant allelic series generated by Cre- and Flp-mediated recombination. Nat Genet 18:136-141.
54. Moon AM, Guris DL, Seo JH, Li L, Hammond J, Talbot A, Imamoto A (2006) Crkl deficiency disrupts Fgf8 signaling in a mouse model of 22q11 deletion syndromes. Dev Cell 10:71-80.
55. Murphy KC (2002) Schizophrenia and velo-cardio-facial syndrome. Lancet 359:426-430.
56. Nowotschin S, Liao J, Gage PJ, Epstein JA, Campione M, Morrow BE (2006) Tbx1 affects asymmetric cardiac morphogenesis by regulating Pitx2 in the secondary heart field. Development 133:1565-1573.
57. Okano J, Sakai Y, Shiota K (2008) Retinoic acid down-regulates Tbx1 expression and induces abnormal differentiation of tongue muscles in fetal mice. Dev Dyn 237:3059-3070.
58. Park EJ, Ogden LA, Talbot A, Evans S, Cai CL, Black BL, Frank DU, Moon AM (2006) Required, tissue-specific roles for Fgf8 in outflow tract formation and remodeling. Development 133:2419- 2433.
59. Paylor R, Glaser B, Mupo A, Ataliotis P, Spencer C, Sobotka A, Sparks C, Choi CH, Oghalai J, Curran S, Murphy KC, Monks S, Williams N, O'Donovan MC, Owen MJ, Scambler PJ, Lindsay E (2006) Tbx1 haploinsufficiency is linked to behavioral disorders in mice and humans: implications for 22q11 deletion syndrome. Proc Natl Acad Sci USA 103:7729-7734.
60. Piotrowski T, Ahn DG, Schilling TF, Nair S, Ruvinsky I, Geisler R, Rauch GJ, Haffter P, Zon LI, Zhou Y, Foott H, Dawid IB, Ho RK (2003) The zebrafish van gogh mutation disrupts tbx1, which is involved in the DiGeorge deletion syndrome in humans. Development 130:5043-5052.
61. Prescott K, Woodfine K, Stubbs P, Super M, Kerr B, Palmer R, Carter NP, Scambler P (2005) A novel 5q11.2 deletion detected by microarray comparative genomic hybridisation in a child referred as a case of suspected 22q11 deletion syndrome. Hum Genet 116:83-90.
62. Raft S, Nowotschin S, Liao J, Morrow BE (2004) Suppression of neural fate and control of inner ear morphogenesis by Tbx1. Development 131:1801-1812.
63. Randall V, McCue K, Roberts C, Kyriakopoulou V, Beddow S, Barrett AN, Vitelli F, Prescott K, Shaw-Smith C, Devriendt K, Bosman E, Steffes G, Steel KP, Simrick S, Basson MA, Illingworth E, Scambler PJ (2009) Great vessel development requires biallelic expression of Chd7 and Tbx1 in pharyngeal ectoderm in mice. J Clin Invest 119:3301-3310.
64. Rauch A, Devriendt K, Koch A, Rauch R, Gewillig M, Kraus C, Weyand M, Singer H, Reis A, Hofbeck M (2004) Assessment of association between variants and haplotypes of the remaining TBX1 gene and manifestations of congenital heart defects in 22q11.2 deletion patients. J Med Genet 41:e40.
65. Roberts C, Ivins SM, James CT, Scambler PJ (2005) Retinoic acid down-regulates Tbx1 expression in vivo and in vitro. Dev Dyn 232:928-938.
66. Roberts C, Ivins S, Cook AC, Baldini A, Scambler PJ (2006) Cyp26 genes a1, b1 and c1 are down-regulated in Tbx1 null mice and inhibition of Cyp26 enzyme function produces a phenocopy of DiGeorge Syndrome in the chick. Hum Mol Genet 15:3394- 3410.
67. Ryan AK, Goodship JA, Wilson DI, Philip N, Levy A, Siedel H, Schuffenhauer S, Oechsler H, Belohradsky B, Priur M, Aurias A, Raymond FL, Clayton-Smith J, Hatchwell E, McKeown C, Beemer FA, Dallapiccola B, Novelli G, Hurst J, Ignatius J, Green AJ, Winter RM, Breuton L, Brondum-Neilsen K, Stewart F, Van Essen T, Patton M, Patterson J, Scambler PJ (1997) Spectrum of clinical features associated with interstitial chromosome 22q11 deletions: a European collaborative study. J Med Genet 34:798-804.
68. Ryckebusch L, Bertrand N, Bajolie F, Niederreither K, Kelly RG, Zaffran S (2009) Decreased levels of embryonic retinoic acid synthesis accelerates recovery from arterial growth delay in a mouse model of DIGeorge syndrome. Weinstein cardiovascular development conference, 87 pp. Ref Type: Abstract.
69. Sakai Y, Meno C, Fujii H, Nishino J, Shiratori H, Saijoh Y, Rossant J, Hamada H (2001) The retinoic acid-inactivating enzyme CYP26 is essential for establishing an uneven distribution of retinoic acid along the anterio-posterior axis within the mouse embryo. Genes Dev 15:213-225.
70. Scambler PJ (2000) The 22q11 deletion syndromes. Hum Mol Genet 9:2421-2426.
71. Shaikh TH, Kurahashi H, Emanuel BS (2001) Evolutionarily conserved low copy repeats (LCRs) in 22q11 mediate deletions, duplications, translocations, and genomic instability: an update and literature review. Genet Med 3:6-13.
72. Shprintzen RJ (2008) Velo-cardio-facial syndrome: 30 Years of study. Dev Disabil Res Rev 14:3-10.
73. Stalmans I, Lambrechts D, De Smet F, Jansen S, Wang J, Maity S, Kneer P, Von Der OM, Swillen A, Maes C, Gewillig M, Molin DG, Hellings P, Boetel T, Haardt M, Compernolle V, Dewerchin M, Plaisance S, Vlietinck R, Emanuel B, Gittenberger-de Groot AC, Scambler P, Morrow B, Driscol DA, Moons L, Esguerra CV, Carmeliet G, Behn-Krappa A, Devriendt K, Collen D, Conway SJ, Carmeliet P (2003) VEGF: a modifier of the del22q11 (Di- George) syndrome? Nat Med 9:173-182.
74. Stoller JZ, Epstein JA (2005) Identification of a novel nuclear localization signal in Tbx1 that is deleted in DiGeorge syndrome patients harboring the 1223delC mutation. Hum Mol Genet 14: 885-892.
75. Taddei I, Morishima M, Huynh T, Lindsay EA (2001) Genetic factors are major determinants of phenotypic variability in a mouse model of the DiGeorge/del22q11 syndromes. Proc Natl Acad Sci USA 98:11428-11431.
76. Torres-Juan L, Rosell J, Morla M, Vidal-Pou C, Garcia-Algas F, de la Fuente MA, Juan M, Tubau A, Bachiller D, Bernues M, Perez-Granero A, Govea N, Busquets X, Heine-Suner D (2007) Mutations in TBX1 genocopy the 22q11.2 deletion and duplication syndromes: a new susceptibility factor for mental retardation. Eur J Hum Genet 15:658-663.
77. Vitelli F, Morishima M, Taddei I, Lindsay EA, Baldini A (2002) Tbx1 mutation causes multiple cardiovascular defects and disrupts neural crest and cranial nerve migratory pathways. Hum Mol Genet 11:915-922.
78. Vitelli F, Taddei I, Morishima M, Meyers EN, Lindsay EA, Baldini A (2002) A genetic link between Tbx1 and fibroblast growth factor signaling. Development 129:4605-4611.
79. Vitelli F, Zhang Z, Huynh T, Sobotka A, Mupo A, Baldini A (2006) Fgf8 expression in the Tbx1 domain causes skeletal abnormalities and modifies the aortic arch but not the outflow tract phenotype of Tbx1 mutants. Dev Biol 295:559-570.
80. Vitelli F, Huynh T, Baldini A (2009) Gain of function of Tbx1 affects pharyngeal and heart development in the mouse. Genesis 47:188-195.
81. Wilson DI, Cross IE, Wren C, Scambler PJ, Burn J, Goodship J (1994) Minimum prevalence of chromosome 22q11 deletions. Am J Hum Genet 55:A169.
82. Xu H, Morishima M, Wylie JN, Schwartz RJ, Bruneau BG, Lindsay EA, Baldini A (2004) Tbx1 has a dual role in the morphogenesis of the cardiac outflow tract. Development 131:3217-3227.
83. Xu H, Cerrato F, Baldini A (2005) Timed mutation and cell-fate mapping reveal reiterated roles of Tbx1 during embryogenesis, and a crucial function during segmentation of the pharyngeal system via regulation of endoderm expansion. Development 132:4387-4395.
84. Xu H, Viola A, Zhang Z, Gerken CP, Lindsay-Illingworth EA, Baldini A (2006) Tbx1 regulates population, proliferation and cell fate determination of otic epithelial cells. Dev Biol 302:670-682.
85. Yagi H, Furutani Y, Hamada H, Sasaki T, Asakawa S, Minoshima S, Ichida F, Joo K, Kimura M, Imamura S, Kamatani N, Momma K, Takao A, Nakazawa M, Shimizu N, Matsuoka R (2003) Role of TBX1 in human del22q11.2 syndrome. Lancet 362:1366-1373.
86. Yashiro K, Shiratori H, Hamada H (2007) Haemodynamics determined by a genetic programme govern asymmetric development of the aortic arch. Nature 450:285-288.
87. Yobb TM, Somerville MJ, Willatt L, Firth HV, Harrison K, Mackenzie J, Gallo N, Morrow BE, Shaffer LG, Babcock M, Chernos J, Bernier F, Sprysak K, Christiansen J, Haase S, Elyas B, Lilley M, Bamforth S, McDermid HE (2005) Microduplication and triplication of 22q11.2: a highly variable syndrome. Am J Hum Genet 76:865-876.
88. Zhang Z, Baldini A (2008) In vivo response to high-resolution variation of Tbx1 mRNA dosage. Hum Mol Genet 17:150-157.
89. Zhang Z, Cerrato F, Xu H, Vitelli F, Morishima M, Vincentz J, Furuta Y, Ma L, Martin JF, Baldini A, Lindsay E (2005) Tbx1 expression in pharyngeal epithelia is necessary for pharyngeal arch artery development. Development 132:5307-5315.
90. Zhang Z, Huynh T, Baldini A (2006) Mesodermal expression of Tbx1 is necessary and sufficient for pharyngeal arch and cardiac outflow tract development. Development 133:3587-3595.
91. Zhang LF, Gui YH, Zhong T, Wang YX, Qian LX, Dong YX, Jiang Q, Sun SN, Song HY (2007) Effect of external retinoic acid on Tbx1 gene during zebrafish embryogenesis. Zhonghua Er Ke Za Zhi 45:267-271.
92. Zweier C, Sticht H, ydin-Yaylagul I, Campbell CE, Rauch A (2007) Human TBX1 missense mutations cause gain of function resulting in the same phenotype as 22q11.2 deletions. Am J Hum Genet 80:510-517.